Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

FGF-1 causes spiral ganglion neurites to branch more.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

The patient's hair had unique damage and a lower sulfur-to-nitrogen ratio compared to relatives, but not compared to healthy controls.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Giant axonal neuropathy changes the structure of keratin in human hair, making it stiffer and stronger.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Giant axonal neuropathy changes the structure of keratin in human hair.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Human dermal fibroblast proteins help restore nerves during healing.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

FilaggrinHigh melanomas have active FGFR signaling and weak GNA14 and Th1 signatures.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.